Research Projects & Grants

For Profit Organization

  • An Open-Label Extension of Studies M15-736 and M20-339 to Evaluate the Safety and Tolerability Of 24-Hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease, Role: Investigator, AbbVie, Inc., (09/2024 - 09/2025) Status: Approved
  • A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson’s Disease Patients. Protocol: M15-736, Role: Investigator, AbbVie, Inc., (02/2021 - 02/2022) Status: Completed

Internal

  • Calciphylaxis: A retrospective review emphasizing the interplay between clinical, histopathologic, and radiographic findings, Role: PI, LLU Dept. of Dermatology, (04/2023) Status: Approved
  • Evaluating patient satisfaction and perspectives of teledermatology at Loma Linda University, Role: PI, LLU Dept. of Dermatology, (06/2021) Status: Completed

Non-Profit Organization

  • An Open-Label Extension of Studies M15-736 and M20-339 to Evaluate the Safety and Tolerability Of 24-Hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease, Role: Investigator, AbbVie, Inc., (09/2024 - 09/2025) Status: Approved
  • A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson’s Disease Patients. Protocol: M15-736, Role: Investigator, AbbVie, Inc., (02/2021 - 02/2022) Status: Completed